Cargando…

Old and new treatment targets in axial spondyloarthritis

Two main treatment targets in axial spondyloarthritis (axSpA) could be currently defined: (1) reduction of inflammation resulting in control of signs and symptoms such as pain and stiffness and (2) prevention or retardation of structural damage progression in the spine resulting in preservation of f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rios Rodriguez, Valeria, Poddubnyy, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Proceedings from OsteoRheumatology 2014
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632151/ https://www.ncbi.nlm.nih.gov/pubmed/26557376 http://dx.doi.org/10.1136/rmdopen-2015-000054

Ejemplares similares

Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?
por: Baraliakos, X, et al.
Publicado: (2015)

New insights into treatment of osteoporosis in postmenopausal women
por: Geusens, Piet
Publicado: (2015)

OsteoRheumatology: a new discipline?
por: Favero, Marta, et al.
Publicado: (2015)

Treatment of complex regional pain syndrome type I with bisphosphonates
por: Giusti, Andrea, et al.
Publicado: (2015)

Rheumatoid arthritis treatment: the earlier the better to prevent joint damage
por: Monti, Sara, et al.
Publicado: (2015)

Structural integrity versus radiographic progression in rheumatoid arthritis
por: Favalli, Ennio Giulio, et al.
Publicado: (2015)

Pathophysiology of osteoarthritis: canonical NF-κB/IKKβ-dependent and kinase-independent effects of IKKα in cartilage degradation and chondrocyte differentiation
por: Olivotto, Eleonora, et al.
Publicado: (2015)

Early knee osteoarthritis
por: Favero, Marta, et al.
Publicado: (2015)

Systemic lupus erythematosus and fractures
por: Bultink, Irene E M, et al.
Publicado: (2015)

Antirheumatic drugs and reproduction in women and men with chronic arthritis
por: Bazzani, Chiara, et al.
Publicado: (2015)

The osteocyte: key player in regulating bone turnover
por: Goldring, Steven R
Publicado: (2015)

Bone and TNF in rheumatoid arthritis: clinical implications
por: Manara, Maria, et al.
Publicado: (2015)

Why does the gout attack stop? A roadmap for the immune pathogenesis of gout
por: Schett, Georg, et al.
Publicado: (2015)

Glucocorticoids: bad or safe for the bones?
por: Lems, Willem F
Publicado: (2015)

Treat-to-target strategy with secukinumab as a first-line biological disease modifying anti-rheumatic drug compared to standard-of-care treatment in patients with active axial spondyloarthritis: protocol for a randomised open-label phase III study, AScalate
por: Poddubnyy, Denis, et al.
Publicado: (2020)

Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial
por: Proft, Fabian, et al.
Publicado: (2021)

Study protocol: Comparison of the effect of treatment with Nonsteroidal anti-inflammatory drugs added to anti-tumour necrosis factor a therapy versus anti-tumour necrosis factor a therapy alone on progression of Structural damage in the spine over two years in patients with ankyLosing spondylitis (CONSUL) – an open-label randomized controlled multicenter trial
por: Proft, Fabian, et al.
Publicado: (2017)

Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns
por: Londono, John, et al.
Publicado: (2015)

(Un)Spoken realities of living with axial spondyloarthritis: a qualitative study focused on couple experiences
por: Raybone, Kerry, et al.
Publicado: (2019)

Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain
por: Benavent, Diego, et al.
Publicado: (2022)

Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining
por: Pearson, Nathan Ashley, et al.
Publicado: (2022)

A glance into the future of diagnosis and treatment of spondyloarthritis
por: Navarro-Compán, Victoria, et al.
Publicado: (2022)

Clinical characteristics of importance to outcome in patients with axial spondyloarthritis: protocol for a prospective descriptive and exploratory cohort study
por: Andreasen, Rikke Asmussen, et al.
Publicado: (2017)

Association of anxiety, depression and resilience with overall health and functioning in axial spondyloarthritis (axSpA): a cross-sectional study
por: Chung, Deborah Xin Yi, et al.
Publicado: (2023)

The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2022)

Treatment of Axial Spondyloarthritis: What Does the Future Hold?
por: Poddubnyy, Denis, et al.
Publicado: (2020)

What is the optimal target for a T2T approach in axial spondyloarthritis?
por: Sieper, Joachim, et al.
Publicado: (2021)

GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis
por: Couderc, Marion, et al.
Publicado: (2020)

Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
por: Uhrenholt, Line, et al.
Publicado: (2019)

Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis
por: Poddubnyy, Denis
Publicado: (2020)

Characteristics of Late-Onset Spondyloarthritis: Data from the Moroccan Registry of Biological Therapies in Rheumatic Diseases
por: Mougui, Ahmed, et al.
Publicado: (2023)

The Efficacy and Safety of Subcutaneous Ixekizumab for the Treatment of Axial Spondylarthritis: A Systematic Review and Meta-Analysis
por: Alzahrani, Ziyad, et al.
Publicado: (2023)

Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis
por: Llop, Maria, et al.
Publicado: (2019)

Sustained clinical response and safety of etanercept in patients with early axial spondyloarthritis: 10-year results of the ESTHER trial
por: Proft, Fabian, et al.
Publicado: (2021)

Patient‐Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis Survey
por: Garrido‐Cumbrera, Marco, et al.
Publicado: (2021)

Effectiveness and cost-effectiveness of combined asynchronous telemonitoring and patient-initiated care for spondyloarthritis: protocol for a pragmatic multicentre randomised controlled trial (TeleSpA Study)
por: Hermans, Kasper, et al.
Publicado: (2023)

HLA-B27 status and inflammatory MRI lesions of the sacroiliac joints: a post hoc analysis in patients without axial spondyloarthritis
por: Ulas, Sevtap Tugce, et al.
Publicado: (2023)

Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis
por: Torgutalp, Murat, et al.
Publicado: (2022)

Choose wisely: imaging for diagnosis of axial spondyloarthritis
por: Diekhoff, Torsten, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b39akhgjtd3mkcous54uaih0da